Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Bronchial Neoplasms

gefitinib has been researched along with Bronchial Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W; Devery, D; di Carlo, C; Hennink, WE; Jockenhoevel, S; Kleinsteinberg, K; Kok, RJ; McGrath, DJ; McHugh, PE1
Balázs, G; Kovalszky, I; Losonczy, G; Moldvay, J; Pápay, J; Puskás, R1
Blandin, S; Gérinière, L; Girard, N; Perrot, E; Souquet, PJ1
Gaya, A; Khorshid, M; Plowman, PN; Walther, JC1
Bréchot, JM1

Other Studies

5 other study(ies) available for gefitinib and Bronchial Neoplasms

ArticleYear
Fabrication and characterization of gefitinib-releasing polyurethane foam as a coating for drug-eluting stent in the treatment of bronchotracheal cancer.
    International journal of pharmaceutics, 2018, Sep-15, Volume: 548, Issue:2

    Topics: Antineoplastic Agents; Bronchial Neoplasms; Drug Liberation; Drug-Eluting Stents; Gefitinib; Polyurethanes; Tracheal Neoplasms; X-Ray Diffraction

2018
[Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission].
    Magyar onkologia, 2014, Volume: 58, Issue:2

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Bronchial Neoplasms; Disease Progression; Docetaxel; ErbB Receptors; Exons; Female; Gefitinib; Gene Deletion; Genes, erbB-1; Humans; Molecular Targeted Therapy; Quinazolines; Remission Induction; Retreatment; Taxoids; Treatment Outcome

2014
[French experience of gefitinib in non-small cell bronchial carcinoma].
    Revue des maladies respiratoires, 2004, Volume: 21, Issue:5 Pt 1

    Topics: Adult; Aged; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Epidermal Growth Factor; Female; Gefitinib; Humans; Male; Middle Aged; Palliative Care; Protein-Tyrosine Kinases; Quinazolines; Retrospective Studies; Sex Factors; Smoking

2004
Cross-over response to erlotinib of brain metastatic disease from bronchial adenocarcinoma after gefitinib failure, and an unusual rash.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:8

    Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; Bronchial Neoplasms; Drug Hypersensitivity; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Middle Aged; Quinazolines; Skin Diseases, Vesiculobullous

2006
[Associations of tyrosine kinase inhibitors with chemotherapy].
    Revue de pneumologie clinique, 2007, Volume: 63, Issue:1 Pt 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Erlotinib Hydrochloride; Gefitinib; Humans; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Treatment Outcome

2007